We next examined the correlation between cyclin E protein alteration and BRCA1 by immunohistochemical staining of cyclin E in 21 breast cancer samples from patients who have germline mutations in BRCA1 treated at the MD Anderson Cancer Center (Figure 1G,H). This evidence concerns the gene BRCA1 and breast cancer.